Allurion Technologies (ALUR) Net Equity Issued and Repurchased (2024 - 2025)
Allurion Technologies (ALUR) posted Net Equity Issued and Repurchased of $14.5 million for Q1 2025, up 3735.71% on a QoQ basis from $378000.0 in Q1 2024, and up 3735.71% year-over-year from $378000.0 in Q1 2024.
Allurion Technologies (ALUR) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Allurion Technologies' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $14.5 million for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2024 | 378,000.00 |
| Mar 31, 2024 | 378,000.00 |